Cite
Burke J, Zhang X, Frey MA, et al. 209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability. Transplantation. 2021;105(12):S17doi: 10.1097/01.tp.0000804368.25112.4d.
Burke, J., Zhang, X., Frey, M. A., Reddy Bobbala, S. K., Richardson, R. A., Allen, S. D., Liu, Y. G., Bohorquez Fuentes, C., Haddad, H. F., Ameer, G. A., & Scott, E. A. (2021). 209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability. Transplantation, 105(12), S17. https://doi.org/10.1097/01.tp.0000804368.25112.4d
Burke, Jacqueline, et al. "209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability." Transplantation vol. 105,12 (2021): S17. doi: https://doi.org/10.1097/01.tp.0000804368.25112.4d
Burke J, Zhang X, Frey MA, Reddy Bobbala SK, Richardson RA, Allen SD, Liu YG, Bohorquez Fuentes C, Haddad HF, Ameer GA, Scott EA. 209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability. Transplantation. 2021 Dec 01;105(12):S17. doi: 10.1097/01.tp.0000804368.25112.4d. PMID: 34908319.
Copy
Download .nbib